P.T. SELATOX BIO PHARMA announced that it will issue 20,000 shares at price of IDR 10,000,000 per share for gross proceeds of IDR 200,000,000,000 on October 27, 2023. The transaction included participation from returning investor Daewoong pharmaceutical Co.,Ltd. This has been approved by the board of directors of the company. The transaction is expected to close on December 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
111,500 KRW | +1.64% | -0.36% | -4.54% |
04-24 | Korean Sugar Imports Plunge 14% as Diabetes Cases Surge | MT |
04-12 | AEON Biopharma, Inc. announced that it has received $15 million in funding from Daewoong Pharmaceutical Co., Ltd | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.54% | 923M | |
+22.69% | 43.81B | |
+25.56% | 23.01B | |
+18.00% | 15.27B | |
+8.91% | 13.68B | |
+42.72% | 11.96B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.26% | 5.59B |
- Stock Market
- Equities
- A069620 Stock
- News Daewoong Pharmaceutical Co., Ltd
- P.T. Selatox Bio Pharma announced that it expects to receive IDR 200 billion in funding from Daewoong Pharmaceutical Co., Ltd